JP2008518914A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008518914A5 JP2008518914A5 JP2007539060A JP2007539060A JP2008518914A5 JP 2008518914 A5 JP2008518914 A5 JP 2008518914A5 JP 2007539060 A JP2007539060 A JP 2007539060A JP 2007539060 A JP2007539060 A JP 2007539060A JP 2008518914 A5 JP2008518914 A5 JP 2008518914A5
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- analgesic
- antipyretic
- calcium carbonate
- alkaline substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 17
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 8
- 239000001095 magnesium carbonate Substances 0.000 claims description 8
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 8
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 8
- 239000000347 magnesium hydroxide Substances 0.000 claims description 8
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 8
- 239000000395 magnesium oxide Substances 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 7
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 12
- 230000000202 analgesic effect Effects 0.000 claims 11
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 10
- 230000001754 anti-pyretic effect Effects 0.000 claims 10
- 239000002221 antipyretic Substances 0.000 claims 9
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 6
- 229960001948 caffeine Drugs 0.000 claims 6
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 229960005489 paracetamol Drugs 0.000 claims 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 4
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 2
- 239000001488 sodium phosphate Substances 0.000 claims 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 1
- QOCMTRJJUAFABS-UHFFFAOYSA-L [Ca++].[O-]C([O-])=O.Cn1cnc2n(C)c(=O)n(C)c(=O)c12 Chemical compound [Ca++].[O-]C([O-])=O.Cn1cnc2n(C)c(=O)n(C)c(=O)c12 QOCMTRJJUAFABS-UHFFFAOYSA-L 0.000 claims 1
- 229940086215 acetaminophen 200 mg Drugs 0.000 claims 1
- 229940086219 acetaminophen 250 mg Drugs 0.000 claims 1
- 229960003563 calcium carbonate Drugs 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 229960003339 sodium phosphate Drugs 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 1
- KLMDYFUUSKOJAX-UHFFFAOYSA-K aluminum;acetate;dihydroxide Chemical compound CC(=O)O[Al](O)O KLMDYFUUSKOJAX-UHFFFAOYSA-K 0.000 description 1
- VXAUWWUXCIMFIM-UHFFFAOYSA-M aluminum;oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Al+3] VXAUWWUXCIMFIM-UHFFFAOYSA-M 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62281204P | 2004-10-28 | 2004-10-28 | |
| PCT/US2005/038507 WO2006049978A1 (en) | 2004-10-28 | 2005-10-26 | Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008518914A JP2008518914A (ja) | 2008-06-05 |
| JP2008518914A5 true JP2008518914A5 (cg-RX-API-DMAC7.html) | 2008-12-04 |
Family
ID=35744599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007539060A Pending JP2008518914A (ja) | 2004-10-28 | 2005-10-26 | アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物 |
Country Status (17)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0607085D0 (en) | 2006-04-07 | 2006-05-17 | Smithkline Beecham Corp | Novel compositions |
| CN100417385C (zh) * | 2006-09-26 | 2008-09-10 | 林星 | 一种用于治疗外伤的外用制剂 |
| GB0707489D0 (en) * | 2007-04-18 | 2007-05-23 | Renaissance Pharma | Compounds |
| CN101596163B (zh) * | 2008-06-06 | 2012-06-27 | 康美保宁(四川)制药有限公司 | 阿咖酚微丸制剂及其制备方法 |
| GB0813929D0 (en) * | 2008-07-30 | 2008-09-03 | Glaxo Group Ltd | Novel method |
| CN102861040B (zh) * | 2012-08-02 | 2014-04-23 | 广东环球制药有限公司 | 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法 |
| CN102949401A (zh) * | 2012-09-06 | 2013-03-06 | 广东九明制药有限公司 | 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺 |
| US10124005B1 (en) * | 2017-12-15 | 2018-11-13 | Lisa Josette Myslinski | Multisymptom migraine combination medication |
| CN110711197B (zh) * | 2018-07-12 | 2023-11-24 | 北京恒润泰生医药科技有限公司 | 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用 |
| CN108853124A (zh) * | 2018-08-15 | 2018-11-23 | 康美保宁(四川)制药有限公司 | 一种阿咖酚制剂及其制剂方法 |
| GB202007670D0 (en) * | 2020-05-22 | 2020-07-08 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Pharmaceutical composition |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4294819A (en) * | 1980-08-18 | 1981-10-13 | Bristol-Myers Company | Alkaline analgesic capsule |
| CA1182049A (en) * | 1981-07-13 | 1985-02-05 | Francis J. Sterbenz | Apap antacid composition |
| US5296241A (en) * | 1991-04-03 | 1994-03-22 | Brimberg Barnett J | Therapeutic composition and method of using same for treatment of hangover |
| JP3122748B2 (ja) * | 1991-11-29 | 2001-01-09 | ライオン株式会社 | イブプロフェン含有解熱鎮痛剤 |
| JP3172749B2 (ja) * | 1992-02-17 | 2001-06-04 | ライオン株式会社 | イブプロフェン含有製剤 |
| JPH06227995A (ja) * | 1993-02-03 | 1994-08-16 | Takeda Chem Ind Ltd | 安定化された固型製剤 |
| JPH07206689A (ja) * | 1994-01-21 | 1995-08-08 | Barnett Lab Ltd | 治療組成物および宿酔の治療のためのこの組成物の使用法 |
| DE19502789A1 (de) * | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Arzneimittel |
| RU2101014C1 (ru) * | 1995-09-07 | 1998-01-10 | Акционерное общество "Курский комбинат лекарственных средств" | Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения |
| GB9704524D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Composition |
| US5972916A (en) * | 1997-07-14 | 1999-10-26 | Bristol-Myers Squibb Company | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
| JP2002012557A (ja) * | 2000-06-28 | 2002-01-15 | Lion Corp | 内服薬組成物 |
| US20040147606A1 (en) * | 2001-05-25 | 2004-07-29 | Yoichi Onuki | Medicinal compositions |
| JP4553552B2 (ja) * | 2003-01-08 | 2010-09-29 | 日東薬品工業株式会社 | 生体リズム応用キット |
-
2005
- 2005-10-26 AU AU2005302618A patent/AU2005302618B2/en not_active Expired
- 2005-10-26 MX MX2007005121A patent/MX2007005121A/es active IP Right Grant
- 2005-10-26 JP JP2007539060A patent/JP2008518914A/ja active Pending
- 2005-10-26 EP EP05821186A patent/EP1807068B1/en not_active Expired - Lifetime
- 2005-10-26 WO PCT/US2005/038507 patent/WO2006049978A1/en not_active Ceased
- 2005-10-26 AR ARP050104491A patent/AR051145A1/es not_active Application Discontinuation
- 2005-10-26 DE DE602005020048T patent/DE602005020048D1/de not_active Expired - Lifetime
- 2005-10-26 CN CNA2005800370243A patent/CN101048155A/zh active Pending
- 2005-10-26 PE PE2005001253A patent/PE20061125A1/es not_active Application Discontinuation
- 2005-10-26 RU RU2007119641/15A patent/RU2398571C2/ru not_active IP Right Cessation
- 2005-10-26 CA CA2583517A patent/CA2583517C/en not_active Expired - Fee Related
- 2005-10-26 US US11/666,528 patent/US20070298096A1/en not_active Abandoned
- 2005-10-26 PL PL05821186T patent/PL1807068T3/pl unknown
- 2005-10-26 BR BRPI0520000-8A patent/BRPI0520000A2/pt not_active IP Right Cessation
- 2005-10-26 AT AT05821186T patent/ATE460930T1/de not_active IP Right Cessation
- 2005-10-26 PT PT05821186T patent/PT1807068E/pt unknown
-
2007
- 2007-05-02 NO NO20072255A patent/NO20072255L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
| WO2005079752A3 (en) | Controlled release pharmaceutical compositions with improved bioavailability | |
| HRP20191892T1 (hr) | Sublingvalna formulacija riluzola | |
| NO20082744L (no) | Oral farmasoytisk doseform omfattende som aktive ingredienser en proton pumpeinhibitor sammen med acetylsalicylsyre | |
| JP5810819B2 (ja) | 積層錠 | |
| EA200602294A1 (ru) | Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества | |
| JP2005068010A5 (cg-RX-API-DMAC7.html) | ||
| ES2644373T3 (es) | Comprimido efervescente que contiene elevado nivel de aspirina | |
| JP7348703B2 (ja) | メロキシカム含有造粒物 | |
| RS59667B1 (sr) | Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe | |
| AR036085A1 (es) | Formas de dosificacion y procedimiento para su fabricacion | |
| Patil et al. | Natural gum as mucoadhesive controlled release carriers: evaluation of Cefpodoxime Proxetil by D-Optimal design technique | |
| JP2008515980A5 (cg-RX-API-DMAC7.html) | ||
| RU2007119641A (ru) | Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции | |
| JP2006232675A (ja) | 複合型口腔内溶解用固形製剤 | |
| JP2009514786A5 (cg-RX-API-DMAC7.html) | ||
| WO2013123487A1 (en) | Alkalized acacia gum adhesive for oral adhering discs | |
| WO2004096125A3 (en) | Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem | |
| WO2001022943A8 (en) | A slow release pharmaceutical composition comprising a magnesium oxychloride cement | |
| JP2013043854A (ja) | 生薬含有製剤 | |
| ES2770141T3 (es) | Comprimido multicapa para administración de magnesio | |
| JP6822034B2 (ja) | 安定性及び速効性の高いイブプロフェン含有固形製剤 | |
| US9422701B2 (en) | Toilet water splash inhibiting device | |
| JP2019116506A (ja) | 固形製剤 | |
| WO2006023295A3 (en) | Pharmaceutical compositions comprising effervescent agents and fenofibrate |